- Megan Paquin

From stiffness to a small tremor or speech changes, the signs of Parkinson’s disease are diverse and often subtle. Although Parkinson’s disease cannot be cured, early detection of the progressive nervous system disorder can make a dramatic difference in helping control symptoms. Scientists at the AdventHealth Translational Research Institute are working on diagnostic advancements to help more patients before they experience significant nervous system damage.
Kirk Erickson, Ph.D., director of translational neuroscience at AdventHealth’s Central Florida Division, was recently part of a research team that has developed a blood test that detects an indicator of Parkinson’s disease. Based on earlier studies that associated mitochondrial DNA damage with an increased risk of Parkinson’s disease, Erickson, as part of a team led by Duke Health, helped develop an assay, or testing procedure, that successfully measures higher levels of mitochondrial DNA damage in blood cells collected from patients with Parkinson’s disease compared to people without the disease. The newly developed test also identified high levels of the damaged DNA in the blood samples of those with the LRRK2 genetic mutation, which has been associated with an increased risk of the disease as well.
"Our research continues as we hope to be able to detect the disease even before our patients present with symptoms."
So, what does this mean for those most at-risk for Parkinson’s disease? Once the test becomes available, future patients may experience shorter wait times to be diagnosed with the disease, enabling potentially greater access to medications and other therapies that may ease symptoms and delay progression.
“This breakthrough is a game-changer,” said Erickson. “Currently, a diagnosis of Parkinson’s disease takes time as it is based on a patient’s medical history, along with a physical and neurological exam. This process is compounded by the fact that many symptoms of Parkinson’s disease can go unnoticed as they begin to affect the body’s nervous system. With a simple blood test, our aim is to reduce the time to diagnosis and help patients get the critical care they need to live longer and more comfortably with Parkinson’s disease.”
Erickson added, “Our research continues as we hope to be able to detect the disease even before our patients present with symptoms.”
The Duke Health team that spearheaded this research was led by senior author Laurie Sanders, Ph.D., an associate professor in Duke School of Medicine’s departments of neurology and pathology and member of the Duke Center for Neurodegeneration and Neurotherapeutics. The research received support from numerous international organizations. To read the study, please visit Science Translational Medicine here.
Recent News
AdventHealth is excited to introduce Eugenio L. Menendez, DO, FACP, to our community of care. He is joining the team at AdventHealth Medical Group Family Medicine at Hendersonville* following the...
Dr. Jeffrey Keen, a board-certified orthopedic surgeon specializing in adult reconstruction, orthopedic surgery, robotic-assisted surgery, and sports medicine, has returned to AdventHealth Medical...
In recognition of National Donate Life Month, nearly 300 transplant patients and their families enjoyed AdventHealth’s 2025 transplant reunion.
According to the National Kidney Foundation, more than 101,000 people are currently on the organ transplant list in need of a new kidney. However, only about 17,000 transplants happen each year —...
The AdventHealth Board of Directors has appointed David Banks as the organization’s new president/CEO, effective immediately.
Ming Wu, MD -- a family medicine doctor with AdventHealth Littleton -- talks about the ways to lessen the impact of seasonal allergies this spring.
In life, Sophie Davis touched dozens of hearts. In passing, one of her organs could possibly save thousands of lives.
As the days get longer and the weather warms up, people are eager to get back to their favorite outdoor spring activities and sports. This transition from winter to spring often leads to an increased...
AdventHealth for Children is a nationally recognized children’s hospital and comprehensive care network caring for nearly 200,000 children annually.
Eight new physicians are joining AdventHealth Ocala’s team to take their next steps to become fully licensed, board-certified family physicians.
Care Management Assistant, Meghan Bussard, was the recipient of the 2024 Outstanding Team Member Award for AdventHealth Shawnee Mission. Bussard is known across AdventHealth Shawnee Mission as a...
Every March, we celebrate Women’s History Month and the countless contributions women have made across all parts of society, including health care. One such area where women have made remarkable...